Examkin

Question

Difficulty: MediumPharmacologic Interventions

A 35-year-old man is brought to the emergency department by emergency medical services due to ongoing generalized shaking of his extremities. The paramedics report that the seizure activity began 20 minutes ago and has been continuous without any periods of responsiveness. His past medical history is significant for a traumatic brain injury two years ago. His blood pressure is 142/88 mmHg, heart rate is 118/min, and oxygen saturation is 95% on a non-rebreather mask. Intravenous access is established, and fingerstick blood glucose is 108 mg/dL (6.0 mmol/L).

Arrange the following pharmacologic interventions in the most appropriate escalating sequence for managing this patient's condition, assuming the seizure activity remains refractory to each preceding step.

  1. 1Intravenous lorazepam
  2. 2Intravenous fosphenytoin
  3. 3Continuous intravenous propofol infusion
  4. 4Continuous intravenous pentobarbital infusion

Answer

The correct escalating sequence is intravenous lorazepam (first-line), followed by intravenous fosphenytoin (second-line), then continuous intravenous propofol infusion (third-line), and finally continuous intravenous pentobarbital infusion (fourth-line).
The algorithm for status epilepticus management is highly protocolized to minimize neuronal injury. In the initial phase (5-20 minutes), rapidly acting benzodiazepines such as intravenous lorazepam are required to acutely halt seizure activity. If seizures persist into the second phase (20-40 minutes), long-acting antiseizure medications like intravenous fosphenytoin, valproic acid, or levetiracetam are administered to achieve sustained seizure control. If clinical or electrographic seizures continue despite these interventions (refractory status epilepticus), continuous anesthetic infusions such as propofol or midazolam are indicated. Finally, for super-refractory status epilepticus that does not respond to initial anesthetic infusions, deep barbiturate coma with pentobarbital is utilized as a therapy of last resort.

Step-by-Step Solution

1
Identify the clinical presentation as status epilepticus.
The patient has had continuous generalized seizure activity for 20 minutes without regaining consciousness, necessitating immediate sequential pharmacologic intervention.
Status epilepticus is a neurologic emergency requiring prompt termination of excitotoxicity.
2
Administer first-line emergent therapy.
Intravenous lorazepam is the initial drug of choice.
Benzodiazepines rapidly enter the central nervous system to enhance GABA-A receptor activity and stop the seizure.
3
Progress to second-line urgent therapy for persistent seizures.
Intravenous fosphenytoin is administered next.
Non-benzodiazepine antiseizure medications provide sustained seizure control but take longer to reach therapeutic brain concentrations.
4
Initiate third-line continuous infusions for refractory status epilepticus.
A continuous intravenous propofol infusion is started.
Anesthetic infusions effectively suppress cortical activity when standard agents fail, though they require intubation and hemodynamic monitoring.
5
Escalate to fourth-line therapy if the condition becomes super-refractory.
A continuous intravenous pentobarbital infusion is initiated.
Barbiturate coma is the final pharmacologic step due to high rates of severe hypotension, immunosuppression, and prolonged recovery times.

Key Concept

The protocolized management of status epilepticus progresses sequentially from rapidly acting benzodiazepines (lorazepam) to long-acting antiseizure medications (fosphenytoin), followed by general anesthetic infusions (propofol), and ultimately barbiturate coma (pentobarbital).
Estimated Time:1m 30s
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic